Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C10AA01	STAVINE	G	Simvastatin - 40mg	40mg	Tablet, scored	207,336 L.L
D06BA51	SILVEZ PLUS	G	Silver sulfadiazine - , Chlorhexidine -		Cream	349,399 L.L
J01DH51	SYNERGIC	G	Imipenem - 500mg, Cilastatin - 500mg		Injectable powder	1,142,266 L.L
A04AA02	SANCUSO	G	Granisetron - 3.1mg/24h	3.1mg/24h	Patch	7,590,728 L.L
M04AA03	STABURIC	G	Febuxostat - 120mg	120mg	Tablet, film coated	1,420,889 L.L
C10AA03	STAVACOR	G	Pravastatin sodium - 40mg	40mg	Tablet, scored	891,799 L.L
L04AX04	SOTIRA	G	Lenalidomide - 10mg	10mg	Capsule	72,248,183 L.L
C10AA03	STAVACOR	G	Pravastatin sodium - 20mg	20mg	Tablet, scored	725,419 L.L
C10AA03	STAVACOR	G	Pravastatin sodium - 10mg	10mg	Tablet, scored	1,695,801 L.L
M04AA03	STABURIC	G	Febuxostat - 80mg	80mg	Tablet, film coated	1,355,489 L.L
M04AA03	STABURIC	G	Febuxostat - 40mg	40mg	Tablet, film coated	1,081,345 L.L
R05C	SULDEX	G	Caffein anyhdrous - 0.216g, Antipyrine - 0.972g, Potassium sulfaguaiacolate - 1.44g		Syrup	152,302 L.L
J05AG03	STOVIRENZ	G	Efavirenz - 600mg	600mg	Tablet, film coated	6,857,456 L.L
B05BC01	SERUFLEX MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
L04AX04	SOTIRA	G	Lenalidomide - 15mg	15mg	Capsule	76,208,289 L.L
B05BC01	SOLUFLEX MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	603,320 L.L
A06AB02	SUPPOLAX	G	Bisacodyl - 10mg	10mg	Suppository	598,051 L.L
M05BA04	STRONDEX 70	G	Alendronate sodium - 70mg	70mg	Tablet	1,305,447 L.L
L01XX02	SPECTRILA	BioTech	Asparaginase, recombinant - 10,000IU	10,000IU	Injectable powder for concentrate for solution	21,370,813 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	L.L
A10BJ02	SAXENDA	BioTech	Liraglutide - 6mg/ml	6mg/ml	Injectable solution	16,747,035 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 100mg/ml	100mg/ml	Injectable solution	57,429,464 L.L
J06BD01	SYNAGIS	BioTech	Palivizumab - 50mg/0.5ml	50mg/0.5ml	Injectable solution	38,316,693 L.L
A10AE54	SULIQUA	BioTech	Insulin glargine - 100IU/ml, Lixisenatide - 50mcg/ml		Injectable solution	11,286,573 L.L
A10AE54	SULIQUA	BioTech	Insulin glargine - 100IU/ml, Lixisenatide - 33mcg/ml		Injectable solution	7,975,793 L.L
L04AB06	SIMPONI	BioTech	Golimumab - 50mg/0.5ml	50mg/0.5ml	Injectable solution	75,598,955 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	L.L
L04AB06	SIMPONI	BioTech	Golimumab - 100mg/1ml	100mg/1ml	Injectable solution	75,598,955 L.L
L04AC02	SIMULECT	BioTech	Basiliximab - 20mg	20mg	Injectable powder + solvent	137,661,787 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	157,788,141 L.L

...